Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-28

FDA Approved: TICAGRELOR — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved Ascend Laboratories' original Abbreviated New Drug Application for ticagrelor, enabling a generic version of the antiplatelet drug to reach the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TICAGRELOR (ticagrelor)

Snippet

ORIG AP for TICAGRELOR (TICAGRELOR)